Format

Send to

Choose Destination
Methods Mol Med. 2005;109:1-18.

Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.

Author information

1
Tumor Vaccine Center, NYU Cancer Institute, New York University School of Medicine, New York, NY, USA.

Abstract

Dendritic cells (DC) are important antigen-presenting cells (APC) that can prime naive T-cells and control lymphocyte-mediated adaptive immune responses with respect to magnitude, memory, and self-tolerance. Understanding the biology of these cells is central to the development of new generation immunotherapies for cancer and chronic infection. This chapter presents a brief overview of DC biology and the preparation and use of DC-based vaccines.

PMID:
15585909
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center